22 Mar Prestige Scientific successfully completed search for Director of Analytical Development
Milford MA. – March 2021 Prestige Scientific announces the successfully completed search for Director of Analytical Development for our rapidly growing clinical stage biopharmaceutical client focused on developing human vaccines for the prevention and treatment of life-threatening infectious diseases.
Critical Objectives: This Director of Analytical Development will report to the Vice President of CMC, and will be responsible for defining and deploying the overall technical and scientific approach to vaccine analytical testing and characterization for the company. This individual will immediately dive in as our client prepares for Phase 2 clinical studies. The individual will utilize their proven track record of success with both drug product and drug substance to advance the company’s pipeline via CDMO partnerships. This person will also actively participate in CMC regulatory strategy development and prepare the requisite CMC components of regulatory filings.
Client Objectives: Our client’s mission is to develop novel approaches to vaccine design and to create clinically-important vaccines which address public health on a global scale.
About Prestige Scientific: Prestige Scientific provides our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own while overcoming challenges and adhering to critical timelines. This systematic approach has proven to decrease our client’s time-to-fill while increasing hiring accuracy. On average our executive searches are completed in 59 days, with the eventual hire presented to the client by the 9th day of the search, with a success rate of 99.7%. Prestige Scientific team members specialize by Practice Area and are deeply anchored in each discipline. Learn more about our expertise.